963 related articles for article (PubMed ID: 32161398)
21. Molecular mechanisms and cellular functions of cGAS-STING signalling.
Hopfner KP; Hornung V
Nat Rev Mol Cell Biol; 2020 Sep; 21(9):501-521. PubMed ID: 32424334
[TBL] [Abstract][Full Text] [Related]
22. Radiotherapy, immunotherapy, and the tumour microenvironment: Turning an immunosuppressive milieu into a therapeutic opportunity.
Donlon NE; Power R; Hayes C; Reynolds JV; Lysaght J
Cancer Lett; 2021 Apr; 502():84-96. PubMed ID: 33450360
[TBL] [Abstract][Full Text] [Related]
23. Intrinsic strategies for the evasion of cGAS-STING signaling-mediated immune surveillance in human cancer: How therapy can overcome them.
Zou SS; Qiao Y; Zhu S; Gao B; Yang N; Liu YJ; Chen J
Pharmacol Res; 2021 Apr; 166():105514. PubMed ID: 33631336
[TBL] [Abstract][Full Text] [Related]
24. Old dogs, new trick: classic cancer therapies activate cGAS.
Yum S; Li M; Chen ZJ
Cell Res; 2020 Aug; 30(8):639-648. PubMed ID: 32541866
[TBL] [Abstract][Full Text] [Related]
25. Role of the cGAS-STING pathway in cancer development and oncotherapeutic approaches.
Khoo LT; Chen LY
EMBO Rep; 2018 Dec; 19(12):. PubMed ID: 30446584
[TBL] [Abstract][Full Text] [Related]
26. Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy.
Lv M; Chen M; Zhang R; Zhang W; Wang C; Zhang Y; Wei X; Guan Y; Liu J; Feng K; Jing M; Wang X; Liu YC; Mei Q; Han W; Jiang Z
Cell Res; 2020 Nov; 30(11):966-979. PubMed ID: 32839553
[TBL] [Abstract][Full Text] [Related]
27. Research progress and clinical application of predictive biomarker for immune checkpoint inhibitors.
Ma K; Jin Q; Wang M; Li X; Zhang Y
Expert Rev Mol Diagn; 2019 Jun; 19(6):517-529. PubMed ID: 31079502
[TBL] [Abstract][Full Text] [Related]
28. Conserved strategies for pathogen evasion of cGAS-STING immunity.
Eaglesham JB; Kranzusch PJ
Curr Opin Immunol; 2020 Oct; 66():27-34. PubMed ID: 32339908
[TBL] [Abstract][Full Text] [Related]
29. Radiation-Induced Remodeling of the Tumor Microenvironment Through Tumor Cell-Intrinsic Expression of cGAS-STING in Esophageal Squamous Cell Carcinoma.
Nakajima S; Mimura K; Kaneta A; Saito K; Katagata M; Okayama H; Saito M; Saze Z; Watanabe Y; Hanayama H; Tada T; Sakamoto W; Momma T; Ohira H; Kono K
Int J Radiat Oncol Biol Phys; 2023 Mar; 115(4):957-971. PubMed ID: 36368436
[TBL] [Abstract][Full Text] [Related]
30. The role of DNA damage repair (DDR) system in response to immune checkpoint inhibitor (ICI) therapy.
Shi C; Qin K; Lin A; Jiang A; Cheng Q; Liu Z; Zhang J; Luo P
J Exp Clin Cancer Res; 2022 Sep; 41(1):268. PubMed ID: 36071479
[TBL] [Abstract][Full Text] [Related]
31. The cGAS-STING pathway: The role of self-DNA sensing in inflammatory lung disease.
Ma R; Ortiz Serrano TP; Davis J; Prigge AD; Ridge KM
FASEB J; 2020 Oct; 34(10):13156-13170. PubMed ID: 32860267
[TBL] [Abstract][Full Text] [Related]
32. cGAS-STING pathway: post-translational modifications and functions in sterile inflammatory diseases.
Hong Z; Ma T; Liu X; Wang C
FEBS J; 2022 Oct; 289(20):6187-6208. PubMed ID: 34310043
[TBL] [Abstract][Full Text] [Related]
33. Regulation of cGAS-STING signalling in cancer: Approach for combination therapy.
Vasiyani H; Wadhwa B; Singh R
Biochim Biophys Acta Rev Cancer; 2023 May; 1878(3):188896. PubMed ID: 37088059
[TBL] [Abstract][Full Text] [Related]
34. Radiation therapy and anti-tumor immunity: exposing immunogenic mutations to the immune system.
Lhuillier C; Rudqvist NP; Elemento O; Formenti SC; Demaria S
Genome Med; 2019 Jun; 11(1):40. PubMed ID: 31221199
[TBL] [Abstract][Full Text] [Related]
35. cGAS-STING signaling encourages immune cell overcoming of fibroblast barricades in pancreatic cancer.
Kabashima A; Matsuo Y; Ito S; Akiyama Y; Ishii T; Shimada S; Masamune A; Tanabe M; Tanaka S
Sci Rep; 2022 Jun; 12(1):10466. PubMed ID: 35773436
[TBL] [Abstract][Full Text] [Related]
36. Targeting STING for cancer immunotherapy: From mechanisms to translation.
Huang R; Ning Q; Zhao J; Zhao X; Zeng L; Yi Y; Tang S
Int Immunopharmacol; 2022 Dec; 113(Pt A):109304. PubMed ID: 36252492
[TBL] [Abstract][Full Text] [Related]
37. Inflammatory signaling in genomically instable cancers.
Talens F; Van Vugt MATM
Cell Cycle; 2019 Aug; 18(16):1830-1848. PubMed ID: 31260383
[TBL] [Abstract][Full Text] [Related]
38. Radiation and Immunotherapy in Upper Gastrointestinal Cancers: The Current State of Play.
Donlon NE; Power R; Hayes C; Davern M; Reynolds JV; Lysaght J
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33499003
[TBL] [Abstract][Full Text] [Related]
39. The cGAS-STING pathway: Post-translational modifications and functional implications in diseases.
Liu J; Rui K; Peng N; Luo H; Zhu B; Zuo X; Lu L; Chen J; Tian J
Cytokine Growth Factor Rev; 2022 Dec; 68():69-80. PubMed ID: 36151014
[TBL] [Abstract][Full Text] [Related]
40. Synthetic enforcement of STING signaling in cancer cells appropriates the immune microenvironment for checkpoint inhibitor therapy.
Vornholz L; Isay SE; Kurgyis Z; Strobl DC; Loll P; Mosa MH; Luecken MD; Sterr M; Lickert H; Winter C; Greten FR; Farin HF; Theis FJ; Ruland J
Sci Adv; 2023 Mar; 9(11):eadd8564. PubMed ID: 36921054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
